{"id":17248,"date":"2020-05-04T02:37:58","date_gmt":"2020-05-04T01:37:58","guid":{"rendered":"https:\/\/sclerodermie.ca\/dre-sabrina-hoa-biographie-2\/"},"modified":"2024-03-28T14:14:06","modified_gmt":"2024-03-28T18:14:06","slug":"dre-sabrina-hoa-biographie","status":"publish","type":"post","link":"https:\/\/sclerodermie.ca\/en\/dre-sabrina-hoa-biographie\/","title":{"rendered":"Dre Sabrina Hoa &#8211; Biographie"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"https:\/\/sclerodermie.ca\/wp-content\/uploads\/2020\/06\/Photo_Hoa.jpg\" width=\"267\" height=\"281\" \/><\/p>\n<p>Sabrina Hoa, MD MSc FRCPC, est rhumatologue, membre du Service de rhumatologie du CHUM, professeure adjointe de clinique au D\u00e9partement de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al et chercheure au Centre de Recherche du CHUM.<\/p>\n<p>Dre Hoa a compl\u00e9t\u00e9 une formation post-doctorale en scl\u00e9rodermie syst\u00e9mique et une Ma\u00eetrise en \u00c9pid\u00e9miologie \u00e0 l\u2019Universit\u00e9 McGill. Son m\u00e9moire portait sur le r\u00f4le des traitements immunosuppresseurs dans la maladie pulmonaire interstitielle l\u00e9g\u00e8re associ\u00e9e \u00e0 la scl\u00e9rodermie, ainsi que sur le r\u00f4le de ces traitements dans la pr\u00e9vention de la maladie pulmonaire. Sa formation \u00e9tait subventionn\u00e9e par une bourse de ma\u00eetrise des Instituts de recherche en sant\u00e9 du Canada (IRSC) et par une bourse post-doctorale de la Soci\u00e9t\u00e9 d\u2019arthrite. Ses travaux de recherche ont \u00e9t\u00e9 s\u00e9lectionn\u00e9s par la Soci\u00e9t\u00e9 d\u2019arthrite comme faisant partie des 10 principales perc\u00e9es de la recherche en 2019.<\/p>\n<h3><span style=\"font-size: 12pt;\"><u>Sujets de recherche:<\/u><\/span><\/h3>\n<ul>\n<li>Approches th\u00e9rapeutiques et pr\u00e9dicteurs de progression dans les formes l\u00e9g\u00e8res de la maladie pulmonaire interstitielle associ\u00e9e \u00e0 la scl\u00e9rodermie.<\/li>\n<li>R\u00f4le des traitements dans la pr\u00e9vention des complications associ\u00e9es \u00e0 la scl\u00e9rodermie.<\/li>\n<li>Signification clinique des auto-anticorps associ\u00e9s \u00e0 la scl\u00e9rodermie et aux maladies pulmonaires interstitielles auto-immunes.<\/li>\n<li>Crit\u00e8res de classification pour la crise r\u00e9nale scl\u00e9rodermique.<\/li>\n<\/ul>\n<h3><span style=\"font-size: 12pt;\"><u>Publications:<\/u><\/span><\/h3>\n<p><strong>Hoa S<\/strong>, Bernatsky S, Steele RJ, Baron M, Hudson M. Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis. Rheumatology (Oxford). 2020 May 1;59(5)\u00a0:1108-1117.<\/p>\n<p><strong>Hoa S<\/strong>, Stern EP, Denton CP, Hudson M. Towards developing criteria for scleroderma renal crisis: A scoping review. Autoimmunity Reviews (2017) 16: 407-415.<\/p>\n<p>Caron M, <strong>Hoa S<\/strong>, Hudson M, Schwartzman K, Steele RJ. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. European Respiratory Review (2018) 27: 1-16.<\/p>\n<p><strong>Hoa S<\/strong>, Leclair V, Hudson M. Cutaneous lymphangiectasia in systemic sclerosis. Arthritis &amp; Rheumatology (2017) 69(2): 446.<\/p>\n<p><strong>Hoa S<\/strong>, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ, Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG), Genetics versus Environment in Scleroderma Outcome Study (GENISOS). Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations. Medicine (Baltimore) (2016) 95: e4713.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sabrina Hoa, MD MSc FRCPC, est rhumatologue, membre du Service de rhumatologie du CHUM, professeure adjointe de clinique au D\u00e9partement de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al et chercheure au Centre de Recherche du CHUM. Dre Hoa a compl\u00e9t\u00e9 une formation post-doctorale en scl\u00e9rodermie syst\u00e9mique et une Ma\u00eetrise en \u00c9pid\u00e9miologie \u00e0 l\u2019Universit\u00e9 McGill. Son m\u00e9moire portait [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[81],"tags":[],"class_list":["post-17248","post","type-post","status-publish","format-standard","hentry","category-portrait-de-chercheurs-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/posts\/17248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/comments?post=17248"}],"version-history":[{"count":14,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/posts\/17248\/revisions"}],"predecessor-version":[{"id":28050,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/posts\/17248\/revisions\/28050"}],"wp:attachment":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/media?parent=17248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/categories?post=17248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/tags?post=17248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}